Need Help? Call 1­-866-­796-­7386
« back to stock screener

  HALO stock: Halozyme Therapeutics, Inc.

Current Rating
Hold/Sell

Previous Rating

Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$41.17
Market Cap
6.09B
Sector
Health Care
Div. Growth
-
P/E
27.0
P/B
50.24
P/S
14.58
Dividend %
-
P/CF
20.1
P/FCF
41.6
Op. Cash Flow
152.2K
FCF
1.0
Op. Margin
58.40%
Net Margin
55.40%
ROE
209.20%
ROI
26.30%
ROA
29.50%
EPS Growth
712.10%
Current Ratio
1.3
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Assertio Holdings Inc (ASRT) $0.90 - - 48.5M Strong Buy
Rigel Pharmaceuticals, Inc. (RIGL) $3.71 - - 709M Strong Buy
Endo International PLC (ENDP) $2.76 - - 499.7M Strong Buy
Sensus Healthcare Inc (SRTS) $3.54 - - 60.2M Strong Buy
Akumin Inc (AKU) $2.44 - - 224.2M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More